Radiopharm Theranostics Ltd
RADX · RDPTF · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Voliotis Dimitris: Form 4
Insider disclosure · Filed · Report period 19 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- RADX · 75041J101 - Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value
Company details and SEC sources
CIK 0001949257 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RADX on Nasdaq, RDPTF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Level 3, 62 Lygon Street, Carlton Vic, 3053
- Incorporated in
- Australia
- Fiscal year end
- 30 June
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields